MIURON
LIVE

Serial Number

90353940

Owner

CiSTEM Inc.

Attorney

Minchul Yang

Filing Date

Dec 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MIURON Trademark

Serial Number: 90353940 • Registration: 6861938

MIURON is a trademark filed by CiSTEM Inc. on December 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CiSTEM Inc. (5 trademarks)

Seoul 06579 , KR

Entity Type: 03

YIPSCELL INC. (4 trademarks)

47-3 BANPODAERO 39GIL, SEOCHOGU
SEOUL 06579 , KR

Entity Type: 03

Trademark Details

Filing Date

December 2, 2020

Registration Date

October 4, 2022

Published for Opposition

July 19, 2022

Goods & Services

pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the treatment of cells; living cells for veterinary purposes; stem cells for veterinary purposes; cytostatics for pharmaceutical purposes; living cells for medical purposes; cellular function activating agents for medical purposes; cytostatics for medical purposes; stem cells for medical purposes; stem cells for pharmaceutical purposes; implantable textile material to encourage the growth of tissue; surgical implants grown from stem cells being living tissues; Biological implants comprised of living tissue for guided tissue regeneration; implantable materials for use in guided tissue regeneration, namely, biological tissue grafts; reagents for use in medical genetic testing; cultures of microorganisms for medical purposes; medical adhesives for binding internal tissue; medical and surgical plasters; Pharmaceutical preparations for chondrocyte treatments using induced pluripotent stem cells

Wholesale store services featuring stem cells for scientific purposes; Wholesale store services featuring stem cells for research purposes; Wholesale store services featuring living cells for veterinary purposes; Wholesale store services featuring stem cells for veterinary purposes; Wholesale store services featuring cytostatics for pharmaceutical purposes; Wholesale store services featuring living cells for medical purposes; Wholesale store services featuring cells for medical purposes; Wholesale store services featuring cellular function activating agents for medical purposes; Wholesale store services featuring cytostatics for medical purposes; Wholesale store services featuring stem cells for medical purposes; Wholesale store services featuring stem cells; Wholesale store services featuring surgical implants grown from stem cells being living tissues; Wholesale store services featuring surgical implants grown from stem cells; Wholesale store services featuring cellchip inspectors; Wholesale store services featuring incubators for cell culture; Wholesale store services featuring apparatus for the regeneration of stem cells for medical purposes; Wholesale store services featuring pharmaceutical preparations for the treatment of cells; Retail store services featuring pharmaceutical preparations for the treatment of cells; Business intermediary services relating to the purchase and sale of pharmaceutical preparations for the treatment of cells; Wholesale store services featuring chondrocyte treatment products using induced pluripotent stem cells

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 4, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 4, 2022 R.PR
REVIEW OF CORRESPONDENCE COMPLETE
Aug 8, 2022 CORV
ASSIGNED TO PETITION STAFF
Aug 3, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 19, 2022 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 7, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 27, 2022 GNFN
FINAL REFUSAL E-MAILED
May 27, 2022 GNFR
FINAL REFUSAL WRITTEN
May 27, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 23, 2022 ERSI
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 11, 2022 ASGN
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 28, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 28, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 28, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 28, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 28, 2021 GNSL
SUSPENSION LETTER WRITTEN
Sep 28, 2021 CNSL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 24, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 24, 2021 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2021 CRFA
ASSIGNED TO LIE
Sep 16, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 4, 2021 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 21, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2021 NWOS
NEW APPLICATION ENTERED
Dec 5, 2020 NWAP